Jump to navigation Jump to search
CAS Number
PubChem CID
E number{{#property:P628}}
ECHA InfoCard{{#property:P2566}}Lua error in Module:EditAtWikidata at line 36: attempt to index field 'wikibase' (a nil value).
Chemical and physical data
Molar mass232.321 g/mol
3D model (JSmol)

5-MeO-2,N,N-trimethyltryptamine (5-MeO-2,N,N-TMT) is a tryptamine derivative that is a hallucinogenic drug. It was invented by Alexander Shulgin and reported in his book TiHKAL (#45) [1]. It is claimed to show psychoactive effects at a dosage of 75-150mg orally, but these are relatively mild compared to other similar drugs, suggesting that while the 2-methyl group has blocked the binding of metabolic enzymes, it is also interfering with binding to the 5HT2A receptor target that mediates the hallucinogenic effects of these drugs.


Template:TiHKAL Template:Hallucinogenic tryptamines Template:Hallucinogen-stub

Template:WikiDoc Sources